NCT01199146View on ClinicalTrials.gov

Abiraterone Post Ketoconazole for Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 10, 2010

Primary Completion Date

January 4, 2013

Study Completion Date

March 14, 2016

Conditions
Prostate Cancer
Interventions
DRUG

Abiraterone acetate

Abiraterone acetate 1000 mg by mouth per day

Trial Locations (2)

60637

University of Chicago, Chicago

94115

University of California, San Francisco, San Francisco

Sponsors
All Listed Sponsors
collaborator

Johnson & Johnson

INDUSTRY

collaborator

Cougar Biotechnology, Inc.

INDUSTRY

lead

University of California, San Francisco

OTHER